Edileia Bagatin

Prof. Dr. Edileia Bagatin

Dermatology, Escola Paulista de Medicina, UNIFESP,, São Paulo, Brazil
orcid
dermatologist, MD, PhD, Universidade Federal de Sao Paulo, B...

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
EBEdileia Bagatin
Edileia Bagatin
CCCaroline Sousa Costa
Caroline Sousa Costa
Acne is a chronic, inflammatory, and immune mediated disease of pilosebaceous unit, highly prevalent in adolescents. It involves face, trunk, and back; may leave scars and affect quality of life. E...

29 July 2022 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
AEAna Cláudia C. Espósito
Ana Cláudia C. Espósito
DCDaniel P. Cassiano
Daniel P. Cassiano
CSCarolina N. da Silva
Carolina N. da Silva
PLPaula B. Lima
Paula B. Lima
JDJoana A. F. Dias
Joana A. F. Dias
HMHelio Miot
Helio Miot
Melasma is a multifactorial dyschromia that results from exposure to external factors (such as solar radiation) and hormonal factors (such as sex hormones and pregnancy), as well as skin inflammation (such as contact dermatitis and esthetic procedures), in genetically predisposed individuals. Beyond hyperfunctional melanocytes, skin with melasma exhibits a series of structural and functional alterations in the epidermis, basement membrane, and upper dermis that interact to elicit and sustain a focal hypermelanogenic phenotype. Evolution in the knowledge of the genetic basis of melasma and the cutaneous response to solar radiation, as well as the roles of endocrine factors, antioxidant system, endothelium proliferation, fibroblast senescence, mast cell degranulation, autophagy deficits of the melanocyte, and the paracrine regulation of melanogenesis, will lead to the development of new treatments and preventive strategies. This review presents current knowledge on these aspects of the pathogenesis of melasma and discusses the effects of specific treatments and future research on these issues.

1 February 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
EBEdileia Bagatin
Edileia Bagatin
TFThais Helena Proença de Freitas
Thais Helena Proença de Freitas
MRMaria Cecilia Rivitti-Machado
Maria Cecilia Rivitti-Machado
BRBeatriz Medeiros Ribeiro
Beatriz Medeiros Ribeiro
SNSamanta Nunes
Samanta Nunes
MRMARCO A D ROCHA
MARCO A D ROCHA
Keywords: Acne vulgaris; Adult; Advanced treatment; Consensus; Hormones; Hyperandrogenism; Skin; Therapeutics

29 July 2022 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
DCDaniel P. Cassiano
Daniel P. Cassiano
AEAna Cláudia C. Espósito
Ana Cláudia C. Espósito
CSCarolina N. da Silva
Carolina N. da Silva
PLPaula B. Lima
Paula B. Lima
JDJoana A. F. Dias
Joana A. F. Dias
EBEdileia Bagatin
Edileia Bagatin
Melasma is a prevalent chronic relapsing pigmentary disorder that affects photoexposed areas, especially in women of childbearing age. Although there is currently no curative treatment available for melasma, this manuscript critically reviews the knowledge regarding photoprotection, topical and oral therapies, and procedures such as peelings, laser, and microneedling that represent the main strategies for control and prevention of this disease. As the pathogenesis of melasma is not entirely understood, there are prospects for the development of new therapeutic strategies that might act on the pathways that promote sustained pigmentation rather than merely decreasing melanin synthesis and removing melanin from the epidermis.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EBEdileia Bagatin
Edileia Bagatin
CCCaroline Sousa Costa
Caroline Sousa Costa
MRMARCO A D ROCHA
MARCO A D ROCHA
FPFabíola Rosa Picosse
Fabíola Rosa Picosse
CKCristhine Souza Leão Kamamoto
Cristhine Souza Leão Kamamoto
HMHelio Miot
Helio Miot
Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria. To communicate the experience and recommendation of Brazilian dermatologists on oral use of the drug in dermatology. Eight experts from five universities were appointed by the Brazilian Society of Dermatology to develop a consensus on indications for this drug. Through the adapted DELPHI methodology, relevant elements were listed and an extensive analysis of the literature was carried out. The consensus was defined with the approval of at least 70% of the experts. With 100% approval from the authors, there was no doubt about the efficacy of oral isotretinoin in the treatment of acne, including as an adjunct in the correction of scars. Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association; they are rare, individual, and should not contraindicate the use of the drug. Regarding unapproved indications, it may represent an option in cases of refractory rosacea, severe seborrheic dermatitis, stabilization of field cancerization with advanced photoaging and, although incipient, frontal fibrosing alopecia. For keratinization disorders, acitretin performs better. In the opinion of the authors, indications for purely esthetic purposes or oil control are not recommended, particularly for women of childbearing age. Approved and non-approved indications, efficacy and adverse effects of oral isotretinoin in dermatology were presented and critically evaluated.

14 May 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
PLPaula Basso Lima
Paula Basso Lima
JDJoana Alexandria Ferreira Dias
Joana Alexandria Ferreira Dias
DCDaniel Pinho Cassiano
Daniel Pinho Cassiano
AEAna Cláudia Cavalcante Esposito
Ana Cláudia Cavalcante Esposito
LMLuciane Donida Bartoli Miot
Luciane Donida Bartoli Miot
HMHelio Miot
Helio Miot